Alpha 2.0
Login Register
» Authors » B Dozin

B Dozin

Explore the profile of B Dozin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 643
Followers 0
Related Specialties
Biochemistry
Cell Biology
Oncology
Top 10 Co-Authors
R Cancedda
R Quarto
V M Nikodem
P Bruzzi
G Campanile
G Canavese
M A Magnuson
F Carli
D Tomei
A Catturich
Published In
J Biol Chem
Biochemistry
Eur J Surg Oncol
J Cell Biol
Eur J Cell Biol
Affiliations
Soon will be listed here.
Recent Articles
1.
A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes
Canavese G, Bruzzi P, Catturich A, Vecchio C, Tomei D, Del Mastro L, et al.
Eur J Surg Oncol . 2014 Apr; 40(7):835-42. PMID: 24684810
Background: Axillary lymph node dissection (ALND) in early-breast cancer patients with positive sentinel node (SLN+) may not always be necessary. Aims: To predict the finding of ≥1 metastatic axillary node...
2.
Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study
Queirolo P, Morabito A, Laurent S, Lastraioli S, Piccioli P, Ascierto P, et al.
Cancer Invest . 2013 May; 31(5):336-45. PMID: 23641913
CTLA-4 blockade with monoclonal antibodies can lead to cancer regression in patients with metastatic melanoma (MM). CTLA-4 gene polymorphisms may influence the response to anti-CTLA-4 antibodies although few data are...
3.
Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study
Ratto G, Costa R, Maineri P, Alloisio A, Piras M, DAgostino A, et al.
Int J Immunopathol Pharmacol . 2012 Jan; 24(4):1005-16. PMID: 22230406
In a previous randomized study, we showed that adjuvant immunotherapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 (rIL-2) significantly improved survival in resected N2-non small cell lung cancer (NSCLC) patients. The...
4.
Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes
Canavese G, Dozin B, Vecchio C, Tomei D, Villa G, Carli F, et al.
Eur J Surg Oncol . 2011 Jun; 37(8):688-94. PMID: 21696914
Background: Feasibility and accuracy of sentinel node biopsy (SLNB) after the delivery of neo-adjuvant chemotherapy (NAC) is controversial. We here report our experience in NAC-treated patients with locally advanced breast...
5.
Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: always or never? A risk/benefit and cost/benefit analysis
Canavese G, Bruzzi P, Catturich A, Vecchio C, Tomei D, Carli F, et al.
Eur J Surg Oncol . 2010 Jul; 36(8):737-44. PMID: 20598494
Aim: To investigate whether omitting intra-operative staging of the sentinel lymph node (SLN) in T1-N0 breast-cancer patients is feasible and convenient because it could allow a more efficient management of...
6.
Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial
Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Villa G, et al.
Ann Oncol . 2009 Jan; 20(6):1001-7. PMID: 19174453
Background: Sentinel lymph node (SLN) staging is currently used to avoid complete axillary dissection in breast cancer patients with negative SLNs. Evidence of a similar efficacy, in terms of survival...
7.
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group
Del Mastro L, Dozin B, Aitini E, Catzeddu T, Baldini E, Contu A, et al.
Ann Oncol . 2007 Oct; 19(2):299-307. PMID: 17947224
Background: The timing of adjuvant chemotherapy and tamoxifen (TAM) has been investigated only in postmenopausal women with breast cancer. We analyzed the outcome of both pre- and postmenopausal women who...
8.
Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications
Giannoni P, Pagano A, Maggi E, Arbico R, Randazzo N, Grandizio M, et al.
Osteoarthritis Cartilage . 2005 Jun; 13(7):589-600. PMID: 15979011
Objective: Proliferation and chondrogenic commitment of cultured articular chondrocytes are impaired when cells derive from aged donors. In those subjects the feasibility of cell-based therapies for articular surface repair is...
9.
Extracellular fatty acid binding protein (ex-FABP) is a stress protein expressed during chondrocyte and myoblast differentiation
Descalzi Cancedda F, Dozin B, Zerega B, Cermelli S, Cancedda R
Osteoarthritis Cartilage . 2001 Oct; 9 Suppl A:S118-22. PMID: 11680675
Objective: We have isolated and characterized in our laboratory a lipocalin specifically binding unsaturated long chain fatty acids (Ex-FABP). In developing chicken embryo long bones, Ex-FABP first appears at the...
10.
Developmental control of chondrogenesis and osteogenesis
Cancedda R, Castagnola P, Cancedda F, Dozin B, Quarto R
Int J Dev Biol . 2000 Nov; 44(6):707-14. PMID: 11061435
During vertebrate embryogenesis, bones of the vertebral column, pelvis, and upper and lower limbs, are formed on an initial cartilaginous model. This process, called endochondral ossification, is characterized by a...